Navigation Links
BioMarin Announces IND for BMN-111 for Achondroplasia is Active
Date:1/3/2012

NOVATO, Calif., Jan. 3, 2012 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the Investigational New Drug (IND) application for BMN-111, an analog of C-type Natriuretic Peptide (CNP), for achondroplasia is active.  The company expects to initiate the Phase 1 trial in the first quarter of 2012.

"BMN-111 has demonstrated benefits in moderately and severely affected animal models and has been shown to promote bone growth even in normal animals," stated Hank Fuchs, M.D., Chief Medical Officer of BioMarin.  "BMN-111 will mark our seventh program in the clinic, the most ever in the history of the company.  We look forward to many potentially value-creating clinical milestones in the coming year."

The primary objective of the Phase 1 trial is to assess the safety and tolerability of single and multiple doses of BMN-111 in normal adult healthy volunteers up to the maximum tolerated dose.  The company expects to start the Phase 2 study in pediatric subjects in the fourth quarter of 2012 or the first quarter of 2013.

About AchondroplasiaAchondroplasia is caused by an autosomal dominant activating mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, a negative regulator of bone growth. Eighty percent of cases are the result of a spontaneous mutation, and ninety-eight percent of those cases have a G380R mutation. Achondroplasia is the most common form of human dwarfism and is characterized by failure of normal conversion of cartilage into bone. Clinical manifestations of the disease include short stature, craniomedullary compression, apnea, bowed legs, frontal bossing and midface hypoplasia, permanent sway of the lower back, spinal stenosis, recurrent ear infections and obesity.

The rate of incidence of achondroplasia is one in 15,000 to one in 40,000 live births, with approximately 18,000 to
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility
2. Highlights from BioMarins Research & Development Day
3. BioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority
4. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
5. BioMarin Announces FDA Approval of Expanded Biologics Manufacturing Facility
6. BioMarin to Host a Research and Development Day on December 8th
7. BioMarin Announces Third Quarter 2011 Financial Results
8. BioMarin to Present at the UBS Global Life Sciences Conference
9. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
10. BioMarin to Present at the Baird Health Care Conference
11. BioMarin to Present at the Wedbush Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition of ... Size, Share, Growth, Trends And Forecast, 2013 - 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 ) Dental consumables ... to treat dental impairments, for tooth restoration and in ...
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... mid-2009, The Michael J. Fox Foundation for Parkinson,s Research ... approaches to Parkinson,s therapeutic development through its groundbreaking ... the safety and efficacy of an FDA-approved drug for ... link between PD and certain strains of influenza virus; ...
... healthcare finding, a peer-reviewed clinical study published in the British ... shows that Prebiotics reduce cholesterol and ... , The controlled clinical study was conducted on rats ... survival rate to 24 months versus a 50% survival rate ...
Cached Medicine Technology:MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33% 2
(Date:4/23/2014)... Michigan State University researcher is looking to give exercise ... and her latest research shows that a cyber buddy ... Games for Health Journal , is the first ... a better motivator during exercise, a software-generated partner also ... something that isn,t real can still motivate people to ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... (April 23, 2014) The American Gastroenterological Association ... 2014 AGA Research Scholars. The AGA Research Scholar ... to develop independent and productive research careers in ... Awards fund an additional year allowing for three ... to supporting junior faculty who are paving the ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
(Date:4/23/2014)... that proliferation of endogenous neural precursor cells cannot ... axons. From the perspective of neural plasticity, Dr. ... in China observed the effects of functional electrical ... and expression of basic fibroblast growth factor and ... the infarct side. The researchers found that functional ...
Breaking Medicine News(10 mins):Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... healthcare reform package that the House is expected to approve today, according to Congressman Chaka Fattah (D-PA-02). , ... , , ... ... ...
... ... , ... This Mother’s Day, Save the Children has a special gift for your mom that can ... For as little as $13 you can buy, in your own mother’s name, one Newborn Care ...
... State Leaders Urged to Support Higher Tobacco Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 ...
... , www.worldsleepday.org , ... , , ... ... ROCHESTER, Minn. , March 18 "A good ...
... ... ... ... March 18 Kids in Missouri will take center stage in the fight against tobacco on March 24 as they join thousands ...
... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 Kids in Montana ...
Cached Medicine News:Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 2Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 3Health News:A Mother's Day Gift that Gives Lasting Joy 2Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health 2Health News:Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health 3Health News:Sleep Well, Stay Healthy: Good Quality and Restorative Sleep Are Essential for Better Mental and Physical Health 4Health News:Missouri Kids 'Kick Butts' on March 24 2Health News:Missouri Kids 'Kick Butts' on March 24 3Health News:Missouri Kids 'Kick Butts' on March 24 4Health News:Missouri Kids 'Kick Butts' on March 24 5Health News:Montana Kids 'Kick Butts' on March 24 2Health News:Montana Kids 'Kick Butts' on March 24 3Health News:Montana Kids 'Kick Butts' on March 24 4Health News:Montana Kids 'Kick Butts' on March 24 5
Indications For Usage: , ,For use during pulmonary lung function testing...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: